Come and participate to the FABS, a new format of symposium that aims to:
- Promote cooperation in science and technology between France and United States
- Promote collaborative initiatives in research and innovation between France and United States in the field of Infectious Diseases
- Participate in the debate between Industry, Biotech Companies and Research Laboratories
- Present needs and skills to firms and public research laboratories
- Develop new opportunities for partnerships and R&D projects between France and United States
Program 2010
| 8.30 am | Registration | ||
| 8.50 am |
Welcome Talks Roger Guillemin - Distinguished Professor, Nobel Prize of Medicine - The Salk Institute for Biological Studies David Martinon - Consul General of France in Los Angeles |
||
| 9.00 am to 12.30 |
Session 1 / Vaccine Development: Innovative Strategies Chairman : Dennis Burton - Ph.D. – Professor in the Department of Immunology, The Scripps Research Institute Dennis Burton - Ph.D. – Professor in the Department of Immunology, The Scripps Research Institute Title: Neutralizing antibodies and an HIV vaccine Marie-Joëlle Frachette - Ph.D. - Director External R&D, Sanofi Pasteur Title: Adjuvanted Flu H1N1 Pandemic vaccine Judit Szecsi - Ph.D. - EVIR, U758, INSERM Title: DNA immunization with constructs coding for virus-like particles: New vaccination strategy against influenza A viruses Greg Lemke - Professor - Molecular Neurobiology Laboratory, The Salk Institute for Biological Studies Title: TAM Receptors, Innate Immunity, and New Vaccine Adjuvants Emmanuel Drouet – Professor at UVHCI UMR 5233 UJF-EMBL-CNRS - Grenoble Title: A new approach for efficient vaccine development: the proteoliposome solution Panel discussion Coffee break and networking Chairman Shane Crotty - Associate Professor - La Jolla Institute for Allergy and Immunology Daniel Scott Algara - M.D., Ph.D., Associate Professor - Pasteur Institute Title: Can we target NK cell subsets in order to obtain better vaccine and immunotherapy responses? Nicolas Pasqual - Ph.D., President CEO & co-founder - ImmunID Technologies Title: BCR&TCR combinatorial repertoire diversity : a promising biomarker of treatment efficiency/risk ratio Vaughn Smider - M.D., Ph.D., Founder & CEO - Fabrus LLC Title: Spatially addressed antibody libraries to discover novel activities Frédéric Legros - Ph.D. - Business Development Manager, Vivalis Title: The EB66 cell line: A enhanced solution for the production of biologics Nathalie Mielcarek - Ph.D., Scientist - Pasteur Institute of Lille Title: Live attenuated Bordetella pertussis as a single-dose nasal vaccine against whooping-cough Panel discussion |
||
| 1.00 pm | Lunch Break | ||
| 2.00 pm to 6.00 pm |
Session 2 – Systems Biology and New Therapeutic Approaches Chairman : Christian Bréchot - Vice President for medical and scientific affairs - Institut Mérieux Sumit Chanda – Ph.D., Associate Professor - Sanford Burnham Research Institute Title: Systems based approaches to identifying viral host-pathogen interactions Suzana Salcedo – Ph.D. - Immunology Centre of Marseille Lumigny, INSERM Title: Understanding how Brucella manipulates and hides within host cells: clues for new therapeutic and vaccine approaches Nevan Krogan - Assistant professor - Department of Cellular and Molecular Pharmacology UC San Francisco (UCSF) Title: Functional insights from protein-protein & genetic interaction maps Pablo Gluschankof - Ph.D., President & Scientific Director - Amikana Biologics Title: Phenotyping HIV resistance through yeast Marianne Manchester – Ph.D., Professor - Skaggs School of Pharmacy and Pharmaceutical Sciences at University of California San Diego Title: Characterizing infection & inflammation by metabolomics Panel discussion Coffee break and networking Chairman : John Young – Ph.D., Professor at the Salk Institute For Biological Studies - La Jolla, CA, USA. Victor Nizet - Professor of Pediatrics & Pharmacy - University of California, San Diego (UCSD) Title: Two "Outside the Box" Approaches to Staphylococcus aureus Therapy Philippe Afonso – Ph.D. - National Health Institute Title: highly active antiretroviral treatment against HTLV-1/STLV-1 infection combining reverse transcriptase and HDAC inhibitors Elizabeth Winzeler - Department Head of the Genomics Institute - The Novartis Research Foundation Title: Using systems biology to discover new drugs for malaria Thomas Baumert – PhD., Professor - University of Strasbourg, INSERM, Hopitaux de Strasbourg Title: Novel antiviral preventive and therapeutic strategies targeting hepatitis C virus entry Panel discussion Keynote Speaker for the conclusive session: Dominique Charron - M.D., Ph.D., Director - UMRS 940 INSERM, IUH, Hôpital Saint-Louis, Professor of Immunology, University of Paris-Diderot, Head Immunology / Histocompatibility Department – AP-HP, Hopital Saint-Louis, Paris INSERM UMRS 940 Title: Immunity & allogeneicity in stem cell therapy |
||
| 6.00 pm | Networking reception | ||